Chemotherapy for metastatic prostate cancer

Chemotherapy is a common treatment for metastatic or advanced prostate cancer. Chemotherapy uses anti cancer drugs to destroy prostate cancer cells. The drugs circulate throughout the body in the bloodstream. The most common type of chemotherapy used for prostate cancer is docetaxel. 

Metastatic prostate cancer is a cancer that began in the prostate and has spread to other parts of the body such as the bones. 

Aim of chemotherapy

Chemotherapy for metastatic prostate cancer can help relieve symptoms. It can also help to control the cancer and improve your quality of life. But it can’t cure metastatic prostate cancer.

What chemotherapy will I have?

The most common types of chemotherapy treatment for metastatic prostate cancer are:

  • docetaxel (Taxotere)
  • cabazitaxel (Jevtana)

You usually have docetaxel first. You may have this with hormone therapy and steroids. 

And then you might have cabazitaxel if your cancer continues to grow after you've had treatment with docetaxel.

Before you start chemotherapy

You need to have blood tests to make sure it’s safe to start treatment. You have these either a few days before or on the day you start treatment. You have blood tests before each round or cycle of treatment.

Your doctors and pharmacists work out your chemotherapy dose based on your blood cell levels, and your weight, height and general health.

How you have chemotherapy

You have docetaxel and cabazitaxel directly into your bloodstream through a drip (intravenously).

Into your bloodstream

You have the treatment through a drip into your arm or hand. A nurse puts a small tube (a cannula) into one of your veins and connects the drip to it.

You might need a central line. This is a long plastic tube that gives the drugs into a large vein, either in your chest or through a vein in your arm. It stays in while you’re having treatment, which may be for a few months.

When you have it

You usually have chemotherapy as cycles of treatment. Each cycle is usually a 3 week period. This means that you have a docetaxel or cabazitaxel drip once every 3 weeks.

Where you have chemotherapy

You usually have treatment into your bloodstream at the cancer day clinic. You might sit in a chair for a few hours so it’s a good idea to take things in to do. For example, newspapers, books or electronic devices can all help to pass the time. You can usually bring a friend or family member with you.

You have some types of chemotherapy over several days. You might be able to have some drugs through a small portable pump that you take home.

For some types of chemotherapy you have to stay in a hospital ward. This could be overnight or for a couple of days.

Some hospitals may give certain chemotherapy treatments to you at home. Your doctor or nurse can tell you more about this.

Dietary or herbal supplements and chemotherapy

Let your doctors know if you:

  • take any supplements
  • have been prescribed anything by alternative or complementary therapy practitioners

It’s unclear how some nutritional or herbal supplements might interact with chemotherapy. They could be harmful.

Side effects

Common chemotherapy side effects include:

  • feeling sick
  • loss of appetite
  • losing weight
  • feeling very tired
  • a lower resistance to infections
  • bleeding and bruising easily
  • diarrhoea or constipation
  • hair loss
Contact your doctor or nurse immediately if you have signs of infection. These include a temperature above 37.5C or below 36C, or generally feeling unwell. Infections can make you very unwell very quickly.

Side effects depend on:

  • which drugs you have
  • how much of each drug you have
  • how you react

Tell your treatment team about any side effects that you have.

Last reviewed: 
21 Jul 2022
Next review due: 
21 Jul 2025
  • Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel
    National Institute for Health and Care Excellence (NICE), 2016

  • Hormone-sensitive metastatic prostate cancer: docetaxel
    National Institute for Health and Care Excellence (NICE), January 2016

  • Cabazitaxel
    Scottish Medicines Consortium (SMC), December 2016

     

  • Prostate cancer: diagnosis and management
    National Institute for Health and Care Excellence (NICE), 2016. Last updated 2021

  • Electronic medicines compendium (eMC)

    Accessed July 2022

Related links